
The Texas Heart Institute Collaborates with Aviara Pharmaceuticals, Inc. to Develop Novel IBD Drug
HOUSTON (Sept. 26, 2023) — Aviara Pharmaceuticals, Inc., through a research collaboration with The Texas Heart Institute® (THI), recently was...
HOUSTON (Sept. 26, 2023) — Aviara Pharmaceuticals, Inc., through a research collaboration with The Texas Heart Institute® (THI), recently was...
HOUSTON (Aug. 22, 2023) — The National Heart, Lung, and Blood Institute (NHLBI) recently awarded The Texas Heart Institute® (THI)...
Texas Heart Institute (THI) Molecular Cardiology researchers Peter Vanderslice, PhD, and Ronald J. Biediger, PhD, were recently awarded a grant from...
HOUSTON, TX (DECEMBER 7, 2021) – The Texas Heart Institute is pleased to announce that Dr. Darren G. Woodside, Senior...
Ronald J. Biediger, Ph.D., a visionary scientist, and inventor, and a highly respected member of the Texas Heart Institute and the...
Technology co-invented by scientists at the Texas Heart Institute and 7 Hills Pharma received broad patent protection from the U.S....
HOUSTON, TX (June 11, 2020) —The Texas Heart Institute and 7 Hills Pharma (7 Hills) received a $1.9 million, Phase...
A promising molecular technology co-invented by scientists at the Texas Heart Institute and 7 Hills could soon enhance the effectiveness...
A promising technology invented at the Texas Heart Institute is one step closer to being tested in a clinical study...
You can see how this popup was set up in our step-by-step guide: https://wppopupmaker.com/guides/auto-opening-announcement-popups/
Visit U.S. News & World Report